Heterodimeric IL-15 regulates the balance of effector and regulatory cells, promoting anti-cancer tumor effects

被引：0
|
作者：
Felber, Barbara [1 ]
Bergamaschi, Cristina [1 ]
Ng, Sin Man [1 ]
Chen, Stephanie [1 ]
Bear, Jenifer [1 ]
Alicea, Candido [1 ]
Beach, Rachel Kelly [1 ]
Chertova, Elena [2 ]
Sowder, Raymond [2 ]
Pavlakis, George [1 ]
机构：
[1] NCI, Ctr Canc Res, Frederick, MD 21701 USA
[2] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA
来源：
JOURNAL OF IMMUNOLOGY | 2015年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CCR4P.213
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model
    Amy E Gillgrass
    Marianne V Chew
    Tamara Krneta
    Ali A Ashkar
    BMC Cancer, 15
  • [32] Mechanism of Heterodimeric IL-15 in tumor reduction: Induction of myeloid-lymphoid cell interactions leads to IFN-γ dependent lymphocyte recruitment by dendritic cells into tumors
    Pavlakis, George N.
    Bergamaschi, Cristina
    Stellas, Dimitri
    Karaliota, Sevasti
    Nagy, Bethany
    Stravokefalou, Vasiliki
    Dimas, Konstantinos
    Jensen, Shawn
    Fox, Bernard A.
    Felber, Barbara K.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [33] IL-15 transpresentation by ovarian cancer cells improves CD34+ progenitor-derived NK cell's anti-tumor functionality
    Vidal-Manrique, M.
    Nieuwenstein, T.
    Hooijmaijers, L.
    de Jonge, P. K. J. D.
    Djojoatmo, M.
    Jansen, J.
    van der Waart, A. B.
    Brock, R.
    Dolstra, H.
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [34] Interleukin-15-Cultered Dendritic Cells Enhance Anti-Tumor Gamme Delta T Cell Functions through IL-15 Secretion
    Van Acker, Heleen H.
    Anguille, Sebastien
    De Reu, Hans
    Berneman, Zwi N.
    Smits, Evelien L.
    Van Tendeloo, Viggo F.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [35] Exercise-induced engagement of the IL-15/1L-15Rα axis promotes anti-tumor immunity in pancreatic cancer
    Kurz, Emma
    Hirsch, Carolina Alcantara
    Dalton, Tanner
    Shadaloey, Sorin Alberto
    Khodadadi-Jamayran, Alireza
    Miller, George
    Pareek, Sumedha
    Rajaei, Hajar
    Mohindroo, Chirayu
    Baydogan, Seyda
    Ngo-Huang, An
    Parker, Nathan
    Katz, Matthew H. G.
    Petzel, Maria
    Vucic, Emily
    McAllister, Florencia
    Schadler, Keri
    Winograd, Rafael
    Bar-Sagi, Dafna
    CANCER CELL, 2022, 40 (07) : 720 - +
  • [36] CD8 T cells inhibit the IL-15 induced expansion of effector cells and the cytotoxic activity of NK cells toward tumour cells in the prostate cancer microenvironment
    Elhage, O.
    Sakellariou, C. A.
    Smith, R. A. G.
    Galustian, C.
    Dasgupta, P.
    BJU INTERNATIONAL, 2015, 115 : 70 - 71
  • [37] IL-35+B cells regulates anti-tumor immune response in pancreatic cancer
    Mirlekar, Bhalchandra
    Pylayeva-Gupta, Yuliya
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [38] Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells
    Sanjabi, Shomyseh
    Mosaheb, Munir M.
    Flavell, Richard A.
    IMMUNITY, 2009, 31 (01) : 131 - 144
  • [39] A novel not-α IL-2 elicits potent anti-tumor activity in mice by improving the effector to regulatory T cell balance.
    Kobayashi, Maki
    Ogama, Naoko
    Kojima, Katsuhiko
    Fukuhara, Tatsuro
    Tanaka, Nobuyuki
    CANCER SCIENCE, 2022, 113
  • [40] A novel not-α IL-2 elicits potent anti-tumor activity in mice by improving the effector to regulatory T cell balance.
    Kobayashi, Maki
    Ogama, Naoko
    Kojima, Katsuhiko
    Fukuhara, Tatsuro
    Tanaka, Nobuyuki
    CANCER SCIENCE, 2021, 112 : 390 - 390
12345